Brass Tax Wealth Management Inc. Purchases 56 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Brass Tax Wealth Management Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,558 shares of the medical equipment provider’s stock after buying an additional 56 shares during the quarter. Brass Tax Wealth Management Inc.’s holdings in Intuitive Surgical were worth $1,257,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. LGT Financial Advisors LLC raised its stake in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the period. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.4 %

Shares of ISRG stock traded down $2.45 during trading on Friday, hitting $542.27. The company’s stock had a trading volume of 175,552 shares, compared to its average volume of 1,435,751. The company has a market cap of $193.15 billion, a PE ratio of 87.58, a P/E/G ratio of 5.35 and a beta of 1.38. The business has a fifty day moving average of $520.67 and a 200-day moving average of $477.52. Intuitive Surgical, Inc. has a 52 week low of $320.26 and a 52 week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. As a group, research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,190 shares of company stock valued at $25,012,927. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on ISRG shares. Raymond James upped their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Wells Fargo & Company upped their price target on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday. Citigroup upped their price target on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday. Truist Financial upped their price target on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Finally, Royal Bank of Canada boosted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $550.28.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.